Veeva Systems reported successful Q2 earnings while securing new CRM adoption deals with Eli Lilly and Biogen.

The entities involved

• Veeva Systems →

  cloud computing company

  • Veea Inc. is listed on the Nasdaq stock exchange, and Geode Capital Management LLC raised its stake in the company, filing with the SEC.Mon 00:19
  • Aclarion and Veeva Systems are being monitored for share price volatility compared to the S&P 500 market index.Sun 14:42
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Biogen →

  American multinational biotechnology company

  • Wyatt Gotbetter was appointed to several senior roles, including President of market access, involving PAREXEL, Cytel, and Biogen.Tue 16:19

Related events

• Regeneron Pharmaceuticals has committed to adopting Veeva Vault CRM globally for its commercial teams, utilizing Veeva's specialized platform services.Aug 25
• Veeva Systems is strategically pivoting its operations, targeting the life sciences CRM market while transitioning from Salesforce's cloud infrastructure to its proprietary Vault platform.Jun 8